Bradley Merrill Thompson, RAC
Medical Device, Digital Health and Combination Product Regulatory Attorney
June 2018
< 1 min reading time
FDA updates Pre-Cert program as it begins to grapple with ‘hard questions’New updates to the FDA’s Software Pre-Cert working model shows the program is making significant gains, but FDA attorney Bradley Merrill Thompson tells FierceHealthcare the agency is starting to bump up against difficult legal and regulatory… source: https://www.linkedin.com/groups/78665/78665-6416841812727595012 Marked as spam
|
Meet your next client here. Join our medical devices group community.
Private answer
Julie Omohundro
In the article, you are quoted as saying that FDA's updated model for the pre-cert program violates the current 510(k) regulation. Could you expand on this?
Marked as spam
|
|
Private answer
Stephen Allan Weitzman
Absolutely correct. The program can only be implemented with new legislation.
Marked as spam
|
|
Private answer
Bradley Merrill Thompson, RAC
Julie, it's a bit complex for a brief comment, but at a high level, the 510(k) requirement is a binding legal requirement. So any new program such as the precert program would need to either meet the terms of that legal requirement, or meet the terms of a specific exemption from that legal requirement. The precert program does neither. I will be expanding on this in the coming days in a separate article.
Marked as spam
|
|
Private answer
Julie Omohundro
So, in essence, FDA doesn't have the legal authority to override the requirement to demonstrate substantial equivalence?
Marked as spam
|
|
Private answer
Julie Omohundro
PS I'm leaning toward the idea that Congress might do well to establish a separate center for standalone medical software products, as they did for tobacco products. What do you think?
Marked as spam
|
|
Private answer
Bradley Merrill Thompson, RAC
Correct, at least without rulemaking and perhaps without statutory authority. There is a regulation on the books that FDA can't simply just ignore.
Marked as spam
|
|
Private answer
Julie Omohundro
I'm not sure about the latter. What's to prevent FDA from ignoring it? If they ignore it, then I think someone would have to pursue this in court? And who would have the motivation to do that? My impression is that the software industry would prefer pre-cert.
Marked as spam
|
|
Private answer
Bradley Merrill Thompson, RAC
There are always unhappy parties with any major change. Consider patient groups, provider groups, insurers and others.
Marked as spam
|
|
Private answer
Julie Omohundro
Agreed, but I'm wondering which, if any, of these unhappy parties might be likely to pursue the matter in court?
Patient groups will sometimes go to court, but they tend to coalesce around a particular disease, condition, or device, rather than this type of broader regulatory issue. If providers and insurers decide they don't trust products coming through FDA via pre-cert instead of 510(k), I wouldn't think they'd go to court. I think they would just not buy/cover them. Marked as spam
|
|